NCT07628296

Brief Summary

The purpose of this study is to collect NIBP and invasive aortic pressure data from the clinical setting.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
12mo left

Started May 2026

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress4%
May 2026Jun 2027

First Submitted

Initial submission to the registry

May 18, 2026

Completed
11 days until next milestone

Study Start

First participant enrolled

May 29, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 5, 2026

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2027

Last Updated

June 8, 2026

Status Verified

May 1, 2026

Enrollment Period

7 months

First QC Date

May 18, 2026

Last Update Submit

June 4, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Primary Outcome Measure

    Collection of non-invasive blood pressure measurements data from subjects in clinical setting.

    Up to 2 hours after time of enrollment

Other Outcomes (1)

  • Incidence of Safety Events

    6 months

Study Arms (3)

Small Adult vs Adult Cuff (Upper Arm, Overlap Range 23-25 cm)

EXPERIMENTAL

Subjects with an upper-arm circumference within 23-25 cm, where both Small Adult (SA) and Adult (A) cuffs are suitable, are randomized in a 1:1 ratio to receive blood pressure measurements using either: * Small Adult cuff, or * Adult cuff Subjects with upper-arm circumferences in non-overlapping SA-only ranges are assigned the Small Adult cuff without randomization and are not included in this arm.

Device: NIBP Measurement

Adult vs Large Adult Cuff (Upper Arm, Overlap Range 31-33 cm)

EXPERIMENTAL

Subjects with an upper-arm circumference within 31-33 cm, where both Adult (A) and Large Adult (LA) cuffs are suitable, are randomized in a 1:1 ratio to receive blood pressure measurements using either: Adult cuff, or Large Adult cuff Subjects with measurements in non-overlapping A-only or LA-only ranges are assigned the appropriate cuff without randomization and are not included in this arm.

Device: NIBP Measurement

Thigh Cuff (Fallback/Non-Randomized)

EXPERIMENTAL

Subjects whose arm circumference is either: * Outside the allowable upper-arm range (17-40 cm), or * Eligible but excluded due to fulfillment of upper-arm cuff quotas will undergo thigh circumference measurement. Those with a thigh circumference within 38-50 cm will receive blood pressure measurements using a thigh cuff. Subjects outside the thigh circumference range are excluded prior to any blood pressure measurements.

Device: NIBP Measurement

Interventions

The collection of non-invasive blood pressure measurements using NIBP Standard Parameter Module with SuperSTAT algorithm with simultaneous invasive blood pressure waveform recordings per discretion of the sponsor upon combining the data from other clinical studies to comply with ISO 81060-2:2018 +AMD2:2024.

Adult vs Large Adult Cuff (Upper Arm, Overlap Range 31-33 cm)Small Adult vs Adult Cuff (Upper Arm, Overlap Range 23-25 cm)Thigh Cuff (Fallback/Non-Randomized)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age requirement: 18 and over.
  • Have an upper limb (right OR left side) that fits the cuff size of the device (circumference ranging 17 cm to 40 cm) OR have a thigh (right OR left side) that fits a cuff size of the device (circumference ranging 38 to 50 cm).
  • Have an arterial line as a standard of care, which measures blood pressure at the aortic root.
  • Able to provide written informed consent.
  • Expected to remain in the unit for the duration of the study procedure.

You may not qualify if:

  • Have previously participated in this study (no subject may participate more than once).
  • Pregnant and lactating women per site standard of care.
  • Subjects with peripheral arterial diseases (causing left/right arm difference)
  • Hemodynamically unstable subjects at the discretion of the investigator.
  • Exhibited injuries, deformities, intravenous lines, or other abnormalities that, in the opinion of the Investigator, may prevent proper cuff application or functioning.
  • Are suffering from infection(s) or immunocompromised patients that require isolation.
  • PI or designee decision due to subject health conditions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tampere Heart Hospital

Tampere, 33521, Finland

RECRUITING

Related Publications (2)

  • Meidert AS, Saugel B. Techniques for Non-Invasive Monitoring of Arterial Blood Pressure. Front Med (Lausanne). 2018 Jan 8;4:231. doi: 10.3389/fmed.2017.00231. eCollection 2017.

    PMID: 29359130BACKGROUND
  • Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW, MacLaughlin EJ, Muntner P, Ovbiagele B, Smith SC Jr, Spencer CC, Stafford RS, Taler SJ, Thomas RJ, Williams KA Sr, Williamson JD, Wright JT Jr. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2018 Oct 23;138(17):e426-e483. doi: 10.1161/CIR.0000000000000597. No abstract available.

    PMID: 30354655BACKGROUND

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 18, 2026

First Posted

June 5, 2026

Study Start

May 29, 2026

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

June 30, 2027

Last Updated

June 8, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Locations